Fractyl Health, Inc. Increase (Decrease) in Accounts Payable
Fractyl Health, Inc. (GUTS) reported Increase (Decrease) in Accounts Payable of -$568.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- Fractyl Health, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$643.00K, a 126.44% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $75.00K.
- Fractyl Health, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $318.00K, a 78.87% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.65M.
- Fractyl Health, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$1.67M, a 162.03% decline from fiscal 2024.
- Fractyl Health, Inc. increase (decrease) in accounts payable for fiscal 2024 was $2.69M.
- Fractyl Health, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$427.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$568.00K 10-Q · filed 2026-08-10 | -$250.00K derived: sum of 3 quarters · filed 2026-08-10 | -$2.90M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $75.00K 10-Q · filed 2026-05-12 | $393.00K derived: sum of 2 quarters · filed 2026-05-12 | -$2.26M derived: sum of 3 quarters · filed 2026-05-12 | $170.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$2.34M derived: sum of 2 quarters · filed 2026-03-24 | $95.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.67M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$223.00K derived: sum of 2 quarters · filed 2026-08-10 | -$1.98M 10-Q · filed 2025-11-12 | -$479.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $671.00K 10-Q · filed 2026-08-10 | $2.18M derived: sum of 3 quarters · filed 2026-08-10 | $1.82M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$1.76M 10-Q · filed 2026-05-12 | -$256.00K derived: sum of 2 quarters · filed 2026-05-12 | -$609.00K derived: sum of 3 quarters · filed 2026-05-12 | $431.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.15M derived: sum of 2 quarters · filed 2026-03-24 | $2.19M derived: sum of 3 quarters · filed 2026-03-24 | $2.69M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$353.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $687.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.18M 10-Q · filed 2025-11-12 | $1.26M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.53M 10-Q · filed 2025-08-12 | $1.61M derived: sum of 3 quarters · filed 2025-08-12 | $1.54M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $494.00K 10-Q · filed 2025-05-13 | $571.00K derived: sum of 2 quarters · filed 2025-05-13 | $501.00K derived: sum of 3 quarters · filed 2025-05-13 | $289.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $7.00K derived: sum of 2 quarters · filed 2025-03-03 | -$205.00K derived: sum of 3 quarters · filed 2025-03-03 | -$427.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$282.00K derived: sum of 2 quarters · filed 2024-11-12 | -$504.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$434.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$222.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |